Home LiteratureArticle Details

PMID: 2712546 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.

Antimicrobial agents and chemotherapy ·Vol. 33 ·No. 1 ·1989-01-00 ·Pages 128-30

Piercy EA, Barbaro D, Luby JP, Mackowiak PA

Abstract

Thirty-seven patients with methicillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy suppressed methicillin-resistant S. aureus colonization in 55% of the patients. Ciprofloxacin-resistant strains emerged in 6 of the 37 patients.

MeSH Terms

Ciprofloxacin/therapeutic use Drug Resistance, Microbial Humans Methicillin/pharmacology Penicillin Resistance Staphylococcal Infections/drug therapy Staphylococcus aureus/drug effects

Chemicals

Ciprofloxacin Methicillin

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Piercy E A

Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas 75235.

Barbaro D

Luby J P

Mackowiak P A

References (13)

13 references, click to expand

Rapid procedure for detection and isolation of large and small plasmids.
J Bacteriol. 1981 Mar;145(3):1365-73 PMID: 7009583
Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak.
Ann Intern Med. 1982 Jan;96(1):11-6 PMID: 7053683
Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection.
Ann Intern Med. 1982 Sep;97(3):317-24 PMID: 7114628
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.
Ann Intern Med. 1982 Sep;97(3):330-8 PMID: 7114630
Nasal carriage of gentamicin and methicillin resistant Staphylococcus aureus treated with topical pseudomonic acid.
Lancet. 1983 Oct 29;2(8357):1036 PMID: 6138588
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
Antimicrob Agents Chemother. 1985 Nov;28(5):634-8 PMID: 2936300
Methicillin-resistant Staphylococcus aureus in Veterans Administration Medical Centers.
Infect Control. 1987 May;8(5):191-4 PMID: 3647939
The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus.
J Antimicrob Chemother. 1986 Mar;17(3):287-95 PMID: 2939049
Outbreak due to methicillin- and rifampin-resistant Staphylococcus aureus: epidemiology and eradication of the resistant strain from the hospital.
Infect Control. 1987 Jan;8(1):15-23 PMID: 3643888
Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization.
Am J Med. 1987 Apr 27;82(4A):215-9 PMID: 3555039
Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak.
Infect Control. 1987 Apr;8(4):145-50 PMID: 3495516
Methicillin-resistant Staphylococcus aureus infections: it's time to get tough.
Infect Control. 1987 May;8(5):187-9 PMID: 3647938
Activity of ciprofloxacin against resistant clinical isolates.
J Antimicrob Chemother. 1986 Mar;17(3):281-6 PMID: 2939048

Article Info

Journal

Antimicrobial agents and chemotherapy

Abbr.

Antimicrob Agents Chemother

ISSN

0066-4804

DOI

10.1128/AAC.33.1.128

Published

1989-01-00

Pages

128-30

Language

English

Region

United States

NLM ID

0315061

PMCID

PMC171438

Subset

External Links

PubMed source DOI: 10.1128/AAC.33.1.128 PMC Full Text View journal details

Analysis Services

Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.

Contact

WeChat Official Account